• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化大鼠对氨基比林的N-去甲基化作用。完整细胞假说的证据。一项形态计量学功能研究。

Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.

作者信息

Reichen J, Arts B, Schafroth U, Zimmermann A, Zeltner B, Zysset T

出版信息

Gastroenterology. 1987 Oct;93(4):719-26. doi: 10.1016/0016-5085(87)90433-1.

DOI:10.1016/0016-5085(87)90433-1
PMID:3623018
Abstract

The intact cell hypothesis states that a reduced number of intrinsically normal hepatocytes, together with hemodynamic alterations, explains decreased drug metabolism in cirrhosis. We explored this hypothesis by comparing results of the aminopyrine breath test with in vitro measurements of aminopyrine N-demethylation and morphometrically determined liver cell volume in a rat model of cirrhosis. Aminopyrine N-demethylation in vivo (ABT-k) was 0.98 +/- 0.10/h (mean +/- SD) in controls. The cirrhotic rats were separated into those with normal (NCR) and those with abnormal ABT-k (PCR). Microsomal aminopyrine N-demethylase averaged 2.08 +/- 0.77 and 2.09 +/- 0.54 mumol/min in controls and NCRs, respectively; it was reduced to 1.00 +/- 0.81 mumol/min (p less than 0.02) in PCRs. Morphometrically determined hepatocellular volume was 18.8 +/- 2.8, 17.1 +/- 1.9, and 11.6 +/- 6.1 ml in controls, NCRs, and PCRs, respectively, PCRs being lower than controls (p less than 0.01) and NCRs (p less than 0.05). When N-demethylase and cytochrome P450 were related to hepatocellular volume (in milliliters), no significant difference between the three groups was apparent. We conclude that reduced aminopyrine N-demethylation in progressed cirrhosis is mainly due to a loss of liver cell volume. The function per liver cell volume remains constant, however, thus favoring the intact cell hypothesis for the handling of slowly metabolized compounds such as aminopyrine.

摘要

完整细胞假说指出,本质正常的肝细胞数量减少,再加上血流动力学改变,可解释肝硬化时药物代谢降低的现象。我们通过在肝硬化大鼠模型中比较氨基比林呼吸试验结果与氨基比林N-脱甲基化的体外测量值以及形态计量学测定的肝细胞体积,对这一假说进行了探究。对照组体内氨基比林N-脱甲基化(ABT-k)为0.98±0.10/小时(均值±标准差)。将肝硬化大鼠分为氨基比林N-脱甲基化正常组(NCR)和异常组(PCR)。对照组和NCR组微粒体氨基比林N-脱甲基酶平均分别为2.08±0.77和2.09±0.54微摩尔/分钟;PCR组则降至1.00±0.81微摩尔/分钟(p<0.02)。形态计量学测定的肝细胞体积在对照组、NCR组和PCR组中分别为18.8±2.8、17.1±1.9和11.6±6.1毫升,PCR组低于对照组(p<0.01)和NCR组(p<0.05)。当N-脱甲基酶和细胞色素P450与肝细胞体积(以毫升计)相关时,三组之间无明显差异。我们得出结论,进展期肝硬化中氨基比林N-脱甲基化降低主要是由于肝细胞体积丧失。然而,每单位肝细胞体积的功能保持不变,因此支持完整细胞假说用于处理诸如氨基比林等代谢缓慢的化合物。

相似文献

1
Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.肝硬化大鼠对氨基比林的N-去甲基化作用。完整细胞假说的证据。一项形态计量学功能研究。
Gastroenterology. 1987 Oct;93(4):719-26. doi: 10.1016/0016-5085(87)90433-1.
2
The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass.
Hepatology. 1987 May-Jun;7(3):457-63. doi: 10.1002/hep.1840070308.
3
Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.单层大鼠原代分离肝细胞系统中氨比林 N-去甲基酶和安替比林羟化酶活性的直接测定。
Biochem Pharmacol. 1981 Sep 1;30(17):2473-9. doi: 10.1016/0006-2952(81)90344-0.
4
Caffeine demethylase activity in human and Dark Agouti rat liver microsomes. Comparison with aminopyrine N-demethylase activity.人和深色刺豚鼠肝脏微粒体中的咖啡因脱甲基酶活性。与氨基比林N-脱甲基酶活性的比较。
Drug Metab Dispos. 1992 May-Jun;20(3):343-9.
5
Differential regulation of liver P-450III cytochromes in choline-deficient rats: implications for the erythromycin breath test as a parameter of liver function.胆碱缺乏大鼠肝脏P-450III细胞色素的差异调节:红霉素呼气试验作为肝功能参数的意义。
Hepatology. 1990 Dec;12(6):1371-8. doi: 10.1002/hep.1840120619.
6
Aminopyrine demethylation measured by breath analysis in cirrhosis.通过呼吸分析测定肝硬化患者的氨基比林去甲基化。
Clin Pharmacol Ther. 1976 Oct;20(4):484-92. doi: 10.1002/cpt1976204484.
7
Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model.大鼠继发性胆汁性肝硬化的结构-功能关系。一种模型的体视学和血流动力学特征
J Hepatol. 1993 Feb;17(2):155-62. doi: 10.1016/s0168-8278(05)80031-5.
8
The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.酮康唑对大鼠体内及体外肝脏氧化药物代谢的影响。
Drug Metab Dispos. 1985 Mar-Apr;13(2):156-62.
9
Hepatic oxidative drug metabolism and the microsomal milieu in a rat model of congenital hyperbilirubinemia.先天性高胆红素血症大鼠模型中的肝脏氧化药物代谢与微粒体环境
Biochem Pharmacol. 1986 Nov 1;35(21):3831-7. doi: 10.1016/0006-2952(86)90672-6.
10
Purification and aminopyrine monooxygenase activity of liver microsomal cytochrome P-450 from alloxan-induced diabetic rats.四氧嘧啶诱导的糖尿病大鼠肝脏微粒体细胞色素P-450的纯化及氨基比林单加氧酶活性
Drug Metab Dispos. 1991 Mar-Apr;19(2):291-7.

引用本文的文献

1
Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls.四氯化碳诱导肝硬化大鼠肝脏中一氧化氮(NO)生物利用度低,可能是由于NO合成减少以及超氧化物歧化酶活性降低,使得超氧化物介导NO分解所致:两种门静脉高压大鼠模型与健康对照的比较。
Comp Hepatol. 2003 Jan 10;2(1):2. doi: 10.1186/1476-5926-2-2.
2
Hepatosplanchnic haemodynamics and renal blood flow and function in rats with liver failure.肝功能衰竭大鼠的肝内脏血流动力学及肾血流量与功能
Gut. 1998 Aug;43(2):272-9. doi: 10.1136/gut.43.2.272.
3
Action of methotrexate on cytochrome P-450 monooxygenases in rats. Study performed with [13C]-aminopyrine micro breath test.
Eur J Drug Metab Pharmacokinet. 1994 Apr-Jun;19(2):119-24. doi: 10.1007/BF03188832.
4
Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.大鼠肝硬化肝功能的决定因素。多变量分析。
J Clin Invest. 1988 Dec;82(6):2069-76. doi: 10.1172/JCI113828.
5
Hepatic circulation: potential for therapeutic intervention.肝循环:治疗干预的潜力。
Pharmacol Ther. 1990;47(2):281-328. doi: 10.1016/0163-7258(90)90091-f.
6
Clinical pharmacokinetics in patients with liver disease.肝病患者的临床药代动力学
Clin Pharmacokinet. 1991 Jul;21(1):42-69. doi: 10.2165/00003088-199121010-00004.
7
Abnormal lipid composition of microsomes from cirrhotic rat liver--does it contribute to decreased microsomal function?肝硬化大鼠肝脏微粒体的脂质组成异常——这是否导致微粒体功能下降?
Experientia. 1992 May 15;48(5):482-6. doi: 10.1007/BF01928168.